Search results
Column: Pharmacy middlemen claim to keep prescription prices low. In fact, they've cost consumers...
LA Times via Yahoo Canada News· 3 hours agoThen came a wave of mergers and acquisitions within the PBM universe, followed by acquisitions by...
FTC poised to sue drug middlemen over insulin prices
Axios· 3 hours agoWhy it matters: The planned suit, first reported by the Wall Street Journal, would follow a two-year FTC investigation that found pharmacy benefit...
US FTC to sue drug middlemen over insulin prices, source says
Reuters via Yahoo Finance Canada· 19 hours ago(Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health...
Middlemen have outsized influence on US drug prices, FTC says
Reuters via Yahoo Finance Canada· 2 days agoWASHINGTON (Reuters) -The consolidation of pharmacies and health insurance companies through years...
Spotlight on PBMs gets harsher
Axios· 16 hours agoThe drumbeat for PBM reforms is intensifying, highlighted by a scathing Federal Trade Commission report on the industry's business practices and a coming...
CVS, UNH, and Cigna Unbowed by Critical FTC Report on Pharmacy Benefit Managers
Barrons.com· 2 days agoThe federal government’s campaign against the pharmacy benefit management industry has escalated...
Pharmacy benefit managers profit at expense of patients and small pharmacies, FTC says
CNN via Yahoo Canada News· 2 days agoPharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of...
FTC preparing suit against drug middlemen over insulin rebates
Los Angeles Times· 12 hours agoThe agency has been investigating whether the rebate practices of insulin manufacturers and three...
Biden health and human services chief rips pharmacy benefit managers during Flint visit
Detroit News· 13 hours agoU.S. Health and Human Services Secretary Xavier Becerra called for funding and policies that support...
Scoop: PBM execs to testify on July 23
Axios· 1 day agoWhy it matters: The hearing adds to mounting bipartisan scrutiny of PBMs as lawmakers consider a flurry of legislation aimed at lowering drug costs by...
